The cannabinoid CB(2) receptor: a good friend in the gut. (Q36922349)

17 August 2017

1 reference

title

The cannabinoid CB(2) receptor: a good friend in the gut. (English)

1 reference

17 August 2017

0 references

0 references

0 references

Izzo AA

1

1 reference

17 August 2017

1 September 2007

1 reference

Neurogastroenterology and Motility

17 August 2017

1 reference

17 August 2017

19

1 reference

17 August 2017

9

1 reference

17 August 2017

704-708

1 reference

Review article: endocannabinoids and their receptors in the enteric nervous system.

17 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00977.X

The gastrointestinal pharmacology of cannabinoids: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00977.X

Involvement of cannabinoid receptors in gut motility and visceral perception

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00977.X

The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00977.X

The endocannabinoid system as an emerging target of pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00977.X

The pharmacology of cannabinoid receptors and their ligands: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00977.X

Targeting the CB2 receptor for immune modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00977.X

Identification and functional characterization of brainstem cannabinoid CB2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00977.X

Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00977.X

Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00977.X

An endogenous cannabinoid tone attenuates cholera toxin-induced fluid accumulation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00977.X

Endocannabinoids induce ileitis in rats via the capsaicin receptor (VR1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00977.X

Possible endocannabinoid control of colorectal cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00977.X

The endogenous cannabinoid system protects against colonic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00977.X

Fatty acid amide hydrolase controls mouse intestinal motility in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00977.X

CB2 cannabinoid receptor agonists: pain relief without psychoactive effects?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00977.X

Therapeutic potential of cannabinoid receptor agonists as analgesic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00977.X

Involvement of cannabinoid receptors in inflammatory hypersensitivity to colonic distension in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00977.X

Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00977.X

Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00977.X

Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00977.X

Cannabinoid 1 (CB1) receptors coupled to cholinergic motorneurones inhibit neurogenic circular muscle contractility in the human colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00977.X

Endocannabinoids as physiological regulators of colonic propulsion in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00977.X

Investigation on the relationship between cannabinoid CB1 and opioid receptors in gastrointestinal motility in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00977.X

Effects of cannabinoid receptor-2 activation on accelerated gastrointestinal transit in lipopolysaccharide-treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00977.X

Role of cannabinoid CB1 receptors and tumor necrosis factor-alpha in the gut and systemic anti-inflammatory activity of SR 141716 (rimonabant) in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00977.X

Cannabinoids and cancer: pros and cons of an antitumour strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2007.00977.X

10.1111/J.1365-2982.2007.00977.X

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

17727390